AU6464400A - Combination treatment with il-1ra and diaryl sulphonyl urea compounds - Google Patents
Combination treatment with il-1ra and diaryl sulphonyl urea compoundsInfo
- Publication number
- AU6464400A AU6464400A AU64644/00A AU6464400A AU6464400A AU 6464400 A AU6464400 A AU 6464400A AU 64644/00 A AU64644/00 A AU 64644/00A AU 6464400 A AU6464400 A AU 6464400A AU 6464400 A AU6464400 A AU 6464400A
- Authority
- AU
- Australia
- Prior art keywords
- combination treatment
- urea compounds
- sulphonyl urea
- diaryl
- diaryl sulphonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15401099P | 1999-09-14 | 1999-09-14 | |
| US60154010 | 1999-09-14 | ||
| PCT/IB2000/001192 WO2001019390A1 (en) | 1999-09-14 | 2000-08-28 | Combination treatment with il-1ra and diaryl sulphonyl urea compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6464400A true AU6464400A (en) | 2001-04-17 |
Family
ID=22549650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU64644/00A Abandoned AU6464400A (en) | 1999-09-14 | 2000-08-28 | Combination treatment with il-1ra and diaryl sulphonyl urea compounds |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1214087A1 (en) |
| JP (1) | JP2003509378A (en) |
| AR (1) | AR033650A1 (en) |
| AU (1) | AU6464400A (en) |
| BR (1) | BR0014003A (en) |
| CA (1) | CA2383026A1 (en) |
| CO (1) | CO5190701A1 (en) |
| EC (1) | ECSP003652A (en) |
| GT (1) | GT200000155A (en) |
| PA (1) | PA8502901A1 (en) |
| PE (1) | PE20010685A1 (en) |
| TN (1) | TNSN00183A1 (en) |
| WO (1) | WO2001019390A1 (en) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1729810T (en) | 2004-04-02 | 2018-11-22 | Swedish Orphan Biovitrum Ab Publ | Methods of reducing aggregation of il-1ra |
| WO2008129288A2 (en) * | 2007-04-19 | 2008-10-30 | Boehringer Ingelheim International Gmbh | Disulfonamides useful in the treatment of inflammation |
| US10538487B2 (en) * | 2015-02-16 | 2020-01-21 | The University Of Queensland | Sulfonylureas and related compounds and use of same |
| BR112018016671A2 (en) | 2016-02-16 | 2018-12-26 | The University Of Queensland | sulfonylureas and related compounds and their use |
| EP3872070A1 (en) | 2016-04-18 | 2021-09-01 | Novartis AG | Compounds and compositions for treating conditions associated with nlrp activity |
| CR20190356A (en) | 2017-01-23 | 2019-11-20 | Genentech Inc | Chemical compounds as inhibitors of interleukin-1 activity |
| US11840543B2 (en) | 2017-05-24 | 2023-12-12 | The University Of Queensland | Compounds and uses |
| EP3634951B8 (en) | 2017-06-09 | 2024-08-21 | Zydus Lifesciences Limited | Novel substituted sulfoximine compounds |
| US11370776B2 (en) | 2017-07-07 | 2022-06-28 | Inflazome Limited | Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors |
| HRP20220195T1 (en) | 2017-07-07 | 2022-04-15 | Inflazome Limited | Novel sulfonamide carboxamide compounds |
| SG11201912166XA (en) | 2017-07-24 | 2020-02-27 | Novartis Inflammasome Research Inc | Compounds and compositions for treating conditions associated with nlrp activity |
| WO2019034692A1 (en) | 2017-08-15 | 2019-02-21 | Inflazome Limited | Sulfonylureas and sulfonylthioureas as nlrp3 inhibitors |
| US11926600B2 (en) | 2017-08-15 | 2024-03-12 | Inflazome Limited | Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors |
| JP2020531448A (en) | 2017-08-15 | 2020-11-05 | インフレイゾーム リミテッド | New sulfonamide carboxamide compounds |
| JP2020531453A (en) | 2017-08-15 | 2020-11-05 | インフレイゾーム リミテッド | Sulfonylurea and Sulfonylurea as NLRP3 Inhibitors |
| US11518739B2 (en) | 2017-08-15 | 2022-12-06 | Inflazome Limited | Sulfonamide carboxamide compounds |
| WO2019043610A1 (en) | 2017-08-31 | 2019-03-07 | Cadila Healthcare Limited | Novel substituted sulfonylurea derivatives |
| US11623922B2 (en) | 2017-10-03 | 2023-04-11 | Inflazome Limited | Compounds |
| EP3707134A1 (en) | 2017-11-09 | 2020-09-16 | Inflazome Limited | Novel sulfonamide carboxamide compounds |
| US11884645B2 (en) | 2018-03-02 | 2024-01-30 | Inflazome Limited | Sulfonyl acetamides as NLRP3 inhibitors |
| WO2019166627A1 (en) | 2018-03-02 | 2019-09-06 | Inflazome Limited | Novel compounds |
| WO2019166619A1 (en) | 2018-03-02 | 2019-09-06 | Inflazome Limited | Novel compounds |
| WO2019166629A1 (en) | 2018-03-02 | 2019-09-06 | Inflazome Limited | Novel compounds |
| WO2019166632A1 (en) | 2018-03-02 | 2019-09-06 | Inflazome Limited | Novel compounds |
| GB201806578D0 (en) * | 2018-04-23 | 2018-06-06 | Inflazome Ltd | Novel compound |
| JP2021529187A (en) | 2018-07-03 | 2021-10-28 | ノバルティス アーゲー | NLRP modulator |
| EP3823726A1 (en) | 2018-07-20 | 2021-05-26 | F. Hoffmann-La Roche SA | Sulfonylurea compounds as inhibitors of interleukin-1 activity |
| EP3870565A1 (en) | 2018-10-24 | 2021-09-01 | Novartis AG | Compounds and compositions for treating conditions associated with nlrp activity |
| JP7488267B2 (en) | 2019-01-14 | 2024-05-21 | ザイダス・ライフサイエンシーズ・リミテッド | Novel substituted sulfonylurea derivatives |
| CA3171969A1 (en) * | 2020-05-25 | 2021-12-02 | Beijing Vdjbio Co., Ltd. | An interleukin-1 receptor antagonist and a fusion protein containing the same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5874424A (en) * | 1995-12-20 | 1999-02-23 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
| ATE242208T1 (en) * | 1997-01-29 | 2003-06-15 | Pfizer | SULFONYL UREA DERIVATIVES AND THEIR USE IN CONTROLLING INTERLEUKIN-1 ACTIVITY |
| US6015790A (en) * | 1997-10-06 | 2000-01-18 | Basf Aktiengesellschaft | Methods and compositions for treating rheumatoid arthritis |
| EP0987552A3 (en) * | 1998-08-31 | 2000-06-07 | Pfizer Products Inc. | Diarylsulfonylurea binding proteins |
-
2000
- 2000-08-28 WO PCT/IB2000/001192 patent/WO2001019390A1/en not_active Application Discontinuation
- 2000-08-28 AU AU64644/00A patent/AU6464400A/en not_active Abandoned
- 2000-08-28 CA CA002383026A patent/CA2383026A1/en not_active Abandoned
- 2000-08-28 JP JP2001523022A patent/JP2003509378A/en active Pending
- 2000-08-28 EP EP00951799A patent/EP1214087A1/en not_active Withdrawn
- 2000-08-28 BR BR0014003-1A patent/BR0014003A/en not_active IP Right Cessation
- 2000-09-05 CO CO00066883A patent/CO5190701A1/en not_active Application Discontinuation
- 2000-09-11 PA PA20008502901A patent/PA8502901A1/en unknown
- 2000-09-12 PE PE2000000942A patent/PE20010685A1/en not_active Application Discontinuation
- 2000-09-12 EC EC2000003652A patent/ECSP003652A/en unknown
- 2000-09-12 AR ARP000104779A patent/AR033650A1/en not_active Application Discontinuation
- 2000-09-13 TN TNTNSN00183A patent/TNSN00183A1/en unknown
- 2000-09-14 GT GT200000155A patent/GT200000155A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001019390A1 (en) | 2001-03-22 |
| PA8502901A1 (en) | 2002-02-21 |
| EP1214087A1 (en) | 2002-06-19 |
| CO5190701A1 (en) | 2002-08-29 |
| JP2003509378A (en) | 2003-03-11 |
| BR0014003A (en) | 2002-05-21 |
| ECSP003652A (en) | 2002-04-23 |
| TNSN00183A1 (en) | 2005-11-10 |
| PE20010685A1 (en) | 2001-07-03 |
| AR033650A1 (en) | 2004-01-07 |
| CA2383026A1 (en) | 2001-03-22 |
| GT200000155A (en) | 2002-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6464400A (en) | Combination treatment with il-1ra and diaryl sulphonyl urea compounds | |
| AU3813499A (en) | The use of dihydropyrimidines as medicaments, and novel substances | |
| AUPP913999A0 (en) | Novel chemical compounds and their use | |
| AU6325599A (en) | New compounds, their preparation and use | |
| AU6325899A (en) | New compounds, their preparation and use | |
| AU6190199A (en) | New compounds, their preparation and use | |
| AU6325799A (en) | New compounds, their preparation and use | |
| AU6190299A (en) | New compounds, their preparation and use | |
| AU5826100A (en) | Benzazepinones and quinazolines | |
| AU6325699A (en) | New compounds, their preparation and use | |
| AU5134499A (en) | Amide, carbamate, and urea derivatives | |
| AU4650199A (en) | Conveyer, conveyer drive, and usage of conveyer | |
| GB9712317D0 (en) | Composition, compound and use | |
| AU6635800A (en) | Pyridomorphinans, thienomoprhinans and use thereof | |
| AU3595099A (en) | New compounds, their preparation and use | |
| AU2841801A (en) | Triazolotriazinones and the use thereof | |
| GB9718876D0 (en) | Compound,composition and use | |
| PL343728A1 (en) | Carbapenem derivatives, utilization thereof and intermediate compounds of the same | |
| EP1469001B8 (en) | Corroles, including chiral derivatives and the use thereof | |
| AU4625100A (en) | Stable catalysts and processes for making and using the same | |
| AU9569998A (en) | Photo-spectrometers, methods of use and manufacture | |
| AU7595298A (en) | Azolidinediones useful for the treatment of diabetes, dyslipidemia and hy pertension | |
| AU5176299A (en) | Compound, composition and use | |
| AU5569200A (en) | Uracil compounds and use thereof | |
| AU6230300A (en) | Substituted guanidines and the use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |